News

EGI joins Philips Healthcare. Press Release. Philips site.

EGI scientists and collaborators to present 5 posters and 4 talks at OHBM. Visitors to the Human Brain Mapping Conference in Vancouver, BC June 25-29 will be able to hear about EGI’s latest research in head modeling and neuromodulation. More.

Preliminary Results of the Epilepsy Trial. EGI announces preliminary results of case studies from the first three patients treated in its safety and feasibility trial for suppressing focal epilepsy with Geodesic Transcranial Electrical Neuromodulation (GTEN). Details.

Recorded webinar on high density EEG. On March 15, 2017, Dr. Mark Mintz delivered a webinar on the research as well as clinical applications of high density EEG and its accuracy in detecting abnormalities. This webinar was organized by ASET. You can view the recorded webinar online. Details. Register for this webinar at the ASET website.

Workshops, Schools, and Symposia

Preliminary results of safety and feasibility for suppressing focal epilepsy with GTEN neuromodulation Brain Stimulation and Imaging Meeting Keynote address by Don Tucker, PhD and CEO of EGI. Saturday, 24 June. Details.

High-Resolution Electrical Head Models for Dense Array Neuromodulation
EGI Lunch Symposium at OHBM 2017 Tuesday, 27 June. Details. Register.

EGI Summer School 2017
Core dEEG Skills July 24-28
Foundations of Advanced dEEG Analysis Techniques July 31-Aug 2.
Details. Register now.

Conferences

Clinical Conferences
Research Conferences

research products button clinical products button

customer publication buttons clinical application button current manuals button

GTEN imageEGI introduces new GTEN 100 neuromodulation

Revealed at the Organization for Human Brain Mapping meeting in Geneva, EGI’s new GTEN 100 System is the most sophisticated non-invasive neuromodulation system on the market, introducing a new level of rigor and precision to this important field of research. EGI’s new GTEN 100 Neuromodulation System includes the ability to choose from 256 electrodes for tDCS, tACS, and tPCS neuromodulation with simultaneous EEG. Planning and targeting software incorporates high-definition electric head models, based on individual MRI scans if desired, for the highest level of precision. Available now for research use.

EGI science team and collaborators will present research on electric head models and neuromodulation at the Brain Stimulation and Imaging Meeting, June 23-24, 2017 and the Organization for Human Brain Mapping 2017 Annual Meeting, June 25-29, 2017 in Vancouver BC. Details.

Register to attend the OHBM Lunch Symposium. Details.

About EGI

EGI is a medical device company that designs, develops and commercialises a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity. A key component of these products is EGI’s proprietary dense array electroencephalography (dEEG) platform technology. The dense array method gathers brain activity data from many more electrodes than conventional EEG products (up to 256), generating significantly higher quality and more precise levels of information. With regulatory clearance in the US, EU and a number of other major international regulatory bodies, the Company’s technology has been increasingly adopted as a powerful research tool and more recently as a cost effective and patient friendly clinical neurodiagnostic platform.

advamed sm logo